Has Ghana's Rotavirus Vaccine Switch Met Programmatic Expectations? An Analysis of National Surveillance Data; 2018-2022
- PMID: 39364172
- PMCID: PMC11447473
- DOI: 10.1093/ofid/ofae539
Has Ghana's Rotavirus Vaccine Switch Met Programmatic Expectations? An Analysis of National Surveillance Data; 2018-2022
Erratum in
-
Correction to: Has Ghana's Rotavirus Vaccine Switch Met Programmatic Expectations? An Analysis of National Surveillance Data; 2018-2022.Open Forum Infect Dis. 2024 Oct 16;11(10):ofae624. doi: 10.1093/ofid/ofae624. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39416996 Free PMC article.
Abstract
Background: Ghana introduced a 2-dose schedule rotavirus vaccine, Rotarix, into childhood immunization in 2012 but switched to a 3-dose schedule vaccine, Rotavac, in 2020 on account of programmatic advantages offered by the latter, including lower cost per fully immunized child and lower cold chain volume requirement. The objective of the study was to assess the effect of the vaccine switch on the trends of rotavirus vaccine uptake and health facility outpatient department (OPD) attendance due to diarrhea among children aged 1-11 months.
Methods: A retrospective analysis was conducted on childhood immunization and diarrhea surveillance data for 2018-2022. The uptake of the different rotavirus vaccine products and the proportion of health facility OPD attendance attributed to diarrhea, respectively, were compared between the pre- and postswitch study periods.
Results: The uptake of rotavirus vaccine was sustained following the switch. There were no significant differences in vaccination coverages (rota1, Rotarix coverage [94.3%], vs rota1, Rotavac coverage [95.3%]; P = .757; rota2, Rotarix coverage [91.3%], vs rota2, Rotavac coverage [92.7%]; P = .789). The proportions of health facility OPD attendance due to diarrhea were comparable (preswitch [12.4%] vs postswitch [12.1%]; P = .838).
Conclusions: Ghana's rotavirus vaccine switch yielded expected programmatic benefits without any untoward effects. The trends of vaccine uptake and reduction in diarrhea morbidity were sustained. These experiences and lessons from the rotavirus vaccine switch are vital for potential switches for other vaccines in the current immunization schedule to mitigate the annual vaccine expenditure.
Keywords: Rotarix; Rotavac; childhood immunization; rotavirus; vaccine switch.
© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts of interest.
Figures
Similar articles
-
Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.PLoS One. 2020 Feb 5;15(2):e0228506. doi: 10.1371/journal.pone.0228506. eCollection 2020. PLoS One. 2020. PMID: 32023295 Free PMC article.
-
Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness.PLOS Glob Public Health. 2023 Aug 9;3(8):e0001328. doi: 10.1371/journal.pgph.0001328. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37556413 Free PMC article.
-
Introducing ROTAVAC® to the occupied Palestinian Territories: Impact on diarrhea incidence, rotavirus prevalence and genotype composition.Vaccine. 2023 Jan 23;41(4):945-954. doi: 10.1016/j.vaccine.2022.12.046. Epub 2022 Dec 28. Vaccine. 2023. PMID: 36585280 Free PMC article.
-
Vaccines for preventing rotavirus diarrhoea: vaccines in use.Cochrane Database Syst Rev. 2019 Oct 28;2019(10):CD008521. doi: 10.1002/14651858.CD008521.pub5. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2021 Nov 17;11:CD008521. doi: 10.1002/14651858.CD008521.pub6. PMID: 31684685 Free PMC article. Updated.
-
Vaccines for preventing rotavirus diarrhoea: vaccines in use.Cochrane Database Syst Rev. 2019 Mar 25;3(3):CD008521. doi: 10.1002/14651858.CD008521.pub4. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2019 Oct 28;2019(10). doi: 10.1002/14651858.CD008521.pub5. PMID: 30912133 Free PMC article. Updated.
References
-
- Mwenda JM, Ntoto KM, Abebe A, et al. Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance Network. J Infect Dis 2010; 202(Suppl):S5–11. - PubMed
-
- Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013; 382:209–22. - PubMed
-
- Damanka S, Adiku TK, Armah GE, et al. Rotavirus infection in children with diarrhea at Korle-Bu Teaching Hospital, Ghana. Jpn J Infect Dis 2016; 69:331–4. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous